Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Immunocore Holdings plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- +5 vs. Q4 2022
- Shares held
- 32.7M
- +2.44M (+8.1%) vs. Q4 2022
- Total value
- $1.61B
- −$111.8M (−6.5%) vs. Q4 2022
- New holders
- 20
- 36 more added
- Sold out
- 15
- 33 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pictet Asset Management SA | 888,951 | $43.9M | 0.06% | +270,636+43.8% | Added |
| General Atlantic LLC | 950,000 | $47.0M | 0.55% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55.7M | 5.28% | +268,331+31.3% | Added |
| Price T Rowe Associates Inc | 1,383,440 | $68.4M | 0.01% | +49,524+3.7% | Added |
| FMR LLC | 2,089,551 | $103.3M | 0.01% | +85,638+4.3% | Added |
| Baker Bros. Advisors LP | 2,520,731 | $124.6M | 0.68% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 3,001,662 | $148.4M | 3.54% | −319,404−9.6% | Reduced |
| Wellington Management Group LLP | 3,375,309 | $166.9M | 0.03% | +1,222,343+56.8% | Added |
| RTW Investments, LP | 5,649,943 | $279.3M | 5.82% | +90,621+1.6% | Added |
| Putnam Investments LLC | 0 | $0 | 0.00% | −32,823−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,883−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −13,975−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 0 | $0 | 0.00% | −11,964−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −11,826−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −6,385−100.0% | Sold out |
| Oversea-Chinese Banking CORP Ltd | 0 | $0 | 0.00% | −5,403−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −4,718−100.0% | Sold out |
| Capital CS Group, LLC | 0 | $0 | 0.00% | −4,422−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −4,045−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −3,996−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Community Bank, N.A. | 0 | $0 | 0.00% | −31−100.0% | Sold out |